Setback for a Schering-Plough Drug
Monday, August 4, 2008 - 08:56
in Health & Medicine
Schering-Plough said regulators had rejected Bridion, its drug to reverse the effects of anesthesia that had been heralded as a breakthrough product by analysts.
Read the whole article on NY Times Health
More from NY Times Health
Related
- New therapy for heart failureThu, 16 Oct 2008, 9:02:20 EDT
- Gene mutation increases drug toxicity, rejection risk in pediatric kidney transplantsWed, 18 Feb 2009, 9:56:22 EST
- Affordable anti-rejection drug as effective as higher cost optionWed, 14 Oct 2009, 12:43:53 EDT
- Scientists develop new cancer-killing compound from salad plantTue, 14 Oct 2008, 10:29:34 EDT
- Cooling the brain prevents cell death in young mice exposed to anesthesiaMon, 17 Nov 2008, 12:49:43 EST